Roche Pharmaceuticals in Ireland

We are proud that 46 medicines developed and/or acquired by Roche are currently included on the World Health Organisation Model Lists of Essential Medicines, which demonstrates the clinical value that the treatment brings to people around the world.

Roche is also dedicated to making a sustainable contribution to society. We have been recognised as a Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry for thirteen years in a row by the Dow Jones Sustainability Indices (DJSI).

We are a force of close to 100,000 people working together across 105 countries, with almost 130 people working right here in Ireland. Our Irish office is located in Dublin and Roche team members here work in access, business strategy, commercial, finance and business operations, healthcare innovation, licence to operate, medical and people and culture. We are proud to have colleagues join the team from around the world and from varied backgrounds and proud of the work we do together. We are networked and collaborative and united in our focus in making Ireland a better place for patients.

Roche is dedicated to supporting patients and patient groups and has provided grants, sponsorships and donations to Irish groups and organisations dedicated to making a difference in the lives of patients. We are committed to patient groups and have built strong and lasting partnerships with organisations such as the Irish Haemophilia Society, the Irish Lung Fibrosis Association, the Marie Keating Foundation and MS Ireland.

As a global pioneer in pharmaceuticals and diagnostics, we have spent more than €3.5 million since 2015 supporting Irish clinical trials, as we seek to find new ways to help people live longer, healthier lives. In the last seven years, Roche has brought 14 new molecules across 28 indications to patients in Ireland. We continue to work with Irish health authorities to give Irish patients the best possible access to new and innovative medicines. Roche is also the number one supplier of hospital medicines in Ireland.

Looking to the future and our mission of doing now what patients need next, we are working hard to advance the concept of 'personalised healthcare' – transforming lives by delivering care tailored to each individual – helping to prevent, diagnose and treat illnesses more effectively.

You can keep up to date with Roche's activities and news in Ireland by following  @RocheIrl  on twitter.

M-IE-00002282 / Date of prep: November 2025

▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this document. You can also report any side effects directly (see details below)